Mainz Biomed NV (MYNZ)
0.6285
-0.04
(-6.19%)
USD |
NASDAQ |
May 14, 16:00
0.6225
-0.01
(-0.95%)
After-Hours: 20:00
Mainz Biomed Gross Profit Margin (Quarterly): 62.74% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.74% |
| September 30, 2023 | 47.99% |
| June 30, 2023 | 59.77% |
| March 31, 2023 | 55.55% |
| Date | Value |
|---|---|
| December 31, 2022 | 18.78% |
| September 30, 2022 | 19.23% |
| June 30, 2022 | 58.04% |
| March 31, 2022 | 46.17% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
18.78%
Minimum
Dec 2022
62.74%
Maximum
Dec 2023
46.03%
Average
51.77%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Affimed NV | -- |
| InflaRx NV | -511.9% |
| MorphoSys AG | 75.20% |
| BioNTech SE | 68.50% |
| Immatics NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -368.8% |
| Return on Assets | -142.3% |
| Return on Invested Capital | -219.3% |
| Profit Margin (Quarterly) | -2.41K% |
| Operating Margin (Quarterly) | -3.17K% |
| Return on Net Operating Assets | -142.4% |